Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.
In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.
As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.
Global Health Limited's hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 and was featured in the list of top 250 global hospitals in 2022 by Newsweek.
The company proposes to utilize the net proceeds of the Fresh Issue towards funding of the following objects:
| IPO Opening Date | Nov 3, 2022 |
|---|---|
| IPO Closing Date | Nov 7, 2022 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹2 Equity Share |
| IPO Price | ₹319 to ₹336 per share |
| Market Lot | 44 Shares |
| Min Order Quantity | 44 Shares |
| Listing At | BSE, NSE |
| Issue Size | [.] shares of ₹2 (aggregating up to ₹2,205.57 Cr) |
| Fresh Issue | [.] shares of ₹2 (aggregating up to ₹500.00 Cr) |
| Offer for Sale | 50,761,000 shares of ₹2 (aggregating up to ₹1,705.57 Cr) |
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
| Basis of Allotment Date | Nov 11, 2022 |
|---|---|
| Initiation of Refunds | Nov 14, 2022 |
| Credit of Shares to Demat Account | Nov 15, 2022 |
| IPO Listing Date | Nov 16, 2022 |
Global Health IPO is a main-board IPO of [.] equity shares of the face value of ₹2 aggregating up to ₹2,205.57 Crores. The issue is priced at ₹319 to ₹336 per share. The minimum order quantity is 44 Shares.
The IPO opens on Nov 3, 2022, and closes on Nov 7, 2022.
KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Global Health IPO opens on Nov 3, 2022 and closes on Nov 7, 2022.
Global Health IPO lot size is 44 Shares and the minimum order quantity is 44 Shares.
You can apply in Global Health IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services.
The finalization of Basis of Allotment for Global Health IPO will be done on Nov 11, 2022, and the allotted shares will be credited to your demat account by Nov 15, 2022.
Check the IPO allotment status.
The Global Health IPO listing date is Nov 16, 2022. The tentative date of Global Health IPO listing is Nov 16, 2022.
To Bid online, you need
Demat Account and Pan card.
Login to SMC account and
select the Global Health IPO
Enter UPI Id & Mobile number
Place your number of bids
with the exchange
A UPI mandate is sent to your
UPI App to block your funds.
